218 related articles for article (PubMed ID: 31895688)
1. Genome-wide DNA copy number profiling and bioinformatics analysis of ovarian cancer reveals key genes and pathways associated with distinct invasive/migratory capabilities.
Liu G; Ruan G; Huang M; Chen L; Sun P
Aging (Albany NY); 2020 Jan; 12(1):178-192. PubMed ID: 31895688
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide DNA copy number analysis in clonally expanded human ovarian cancer cells with distinct invasive/migratory capacities.
Li L; Bai H; Yang J; Cao D; Shen K
Oncotarget; 2017 Feb; 8(9):15136-15148. PubMed ID: 28122348
[TBL] [Abstract][Full Text] [Related]
3. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
4. AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer.
Svoboda M; Meshcheryakova A; Heinze G; Jaritz M; Pils D; Castillo-Tong DC; Hager G; Thalhammer T; Jensen-Jarolim E; Birner P; Braicu I; Sehouli J; Lambrechts S; Vergote I; Mahner S; Zimmermann P; Zeillinger R; Mechtcheriakova D
BMC Genomics; 2016 Aug; 17(1):643. PubMed ID: 27527602
[TBL] [Abstract][Full Text] [Related]
5. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis.
Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B
J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638
[TBL] [Abstract][Full Text] [Related]
6. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive allelotype study of ovarian tumors of low malignant potential: potential differences in pathways between tumors with and without genetic predisposition to invasive carcinoma.
Nakayama K; Takebayashi Y; Namiki T; Tamahashi N; Nakayama S; Uchida T; Miyazaki K; Fukumoto M
Int J Cancer; 2001 Nov; 94(4):605-9. PubMed ID: 11745452
[TBL] [Abstract][Full Text] [Related]
8. Integrated Genome-Wide Analysis of Gene Expression and DNA Copy Number Variations Highlights Stem Cell-Related Pathways in Small Cell Esophageal Carcinoma.
Liu D; Xu X; Wen J; Xie L; Zhang J; Shen Y; Jiang G; Chen J; Fan M
Stem Cells Int; 2018; 2018():3481783. PubMed ID: 30228821
[No Abstract] [Full Text] [Related]
9. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
[TBL] [Abstract][Full Text] [Related]
10. Global patterns of large copy number variations in the human genome reveal complexity in chromosome organization.
Veerappa AM; Suresh RV; Vishweswaraiah S; Lingaiah K; Murthy M; Manjegowda DS; Padakannaya P; Ramachandra NB
Genet Res (Camb); 2015 Sep; 97():e18. PubMed ID: 26390810
[TBL] [Abstract][Full Text] [Related]
11. Identification of copy number variation-driven genes for liver cancer via bioinformatics analysis.
Lu X; Ye K; Zou K; Chen J
Oncol Rep; 2014 Nov; 32(5):1845-52. PubMed ID: 25174835
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
Liu X; Li G
Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
[TBL] [Abstract][Full Text] [Related]
13. aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations.
Renault V; Tost J; Pichon F; Wang-Renault SF; Letouzé E; Imbeaud S; Zucman-Rossi J; Deleuze JF; How-Kit A
PLoS One; 2017; 12(12):e0189334. PubMed ID: 29261730
[TBL] [Abstract][Full Text] [Related]
14. [Study of the metastasis-associated genes and its copy numbers variation in highly metastatic epithelial ovarian cancer].
Ying LS; Xu SH; Su D; Mou HZ; Gu LH; Zhu CH; Liu XL
Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):126-30. PubMed ID: 19570424
[TBL] [Abstract][Full Text] [Related]
15. RAD51AP1 promotes progression of ovarian cancer via TGF-β/Smad signalling pathway.
Zhao H; Gao Y; Chen Q; Li J; Ren M; Zhao X; Yue W
J Cell Mol Med; 2021 Feb; 25(4):1927-1938. PubMed ID: 33314567
[TBL] [Abstract][Full Text] [Related]
16. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
17. Multi-Omics Analysis Identifying Key Biomarkers in Ovarian Cancer.
Li JY; Li CJ; Lin LT; Tsui KH
Cancer Control; 2020; 27(1):1073274820976671. PubMed ID: 33297760
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of enhancer regulatory circuit perturbation driven by copy number variations in malignant glioma.
Xiao J; Jin X; Zhang C; Zou H; Chang Z; Han N; Li X; Zhang Y; Li Y
Theranostics; 2021; 11(7):3060-3073. PubMed ID: 33537074
[No Abstract] [Full Text] [Related]
19. DNA copy number profiling in microsatellite-stable and microsatellite-unstable hereditary non-polyposis colorectal cancers by targeted CNV array.
Chen W; Ding J; Jiang L; Liu Z; Zhou X; Shi D
Funct Integr Genomics; 2017 Jan; 17(1):85-96. PubMed ID: 27896456
[TBL] [Abstract][Full Text] [Related]
20. Machine learning and bioinformatics models to identify gene expression patterns of ovarian cancer associated with disease progression and mortality.
Hossain MA; Saiful Islam SM; Quinn JMW; Huq F; Moni MA
J Biomed Inform; 2019 Dec; 100():103313. PubMed ID: 31655274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
